Inventor · disambiguated record
Arwinder Nagi
Also filed as: NAGI ARWINDER · NAGI ARWINDER S · NAGI ARWINDER SINGH
16 granted patents·20 pending applications·362 citations·filing 1998–2014
94Inventor score
Top patents by PatentIndex Score
36 records- 0195US5989591ARapamycin formulations for oral administrationAMERICAN HOME PROD·Filed 1998·Granted Nov 23, 1999·174 cites·14 claims
- 0288US7838027B2Pantoprazole multiparticulate formulationsWYETH LLC·Filed 2004·Granted Nov 23, 2010·27 cites·24 claims
- 0388US7767668B2Micronized tanaproget, compositions, and methods of preparing the sameWYETH LLC·Filed 2006·Granted Aug 3, 2010·14 cites·36 claims
- 0486US8790708B2Coated tablet formulations and uses thereofWYETH LLC·Filed 2013·Granted Jul 29, 2014·14 cites·23 claims
- 0586US8518446B2Coated tablet formulations and uses thereofASHRAF MUHAMMAD·Filed 2010·Granted Aug 27, 2013·20 cites·18 claims
- 0686US5985325ARapamycin formulations for oral administrationAMERICAN HOME PROD·Filed 1998·Granted Nov 16, 1999·78 cites·9 claims
- 0785US7786297B2Purified form of tanaprogetWYETH LLC·Filed 2006·Granted Aug 31, 2010·10 cites·13 claims
- 0885US7553498B2Pantoprazole multiparticulate formulationsWYETH CORP·Filed 2007·Granted Jun 30, 2009·7 cites·7 claims
- 0983US7550153B2Pantoprazole multiparticulate formulationsWYETH CORP·Filed 2007·Granted Jun 23, 2009·5 cites·21 claims
- 1076US8343965B2Compositions containing micronized tanaproget prepared by wet granulationWYETH LLC·Filed 2006·Granted Jan 1, 2013·3 cites·31 claims
- 1174US8450312B2Micronized tanaproget, compositions, and methods of preparing the sameNAGI ARWINDER S·Filed 2010·Granted May 28, 2013·3 cites·20 claims
- 1273US7544370B2Pantoprazole multiparticulate formulationsWYETH CORP·Filed 2004·Granted Jun 9, 2009·5 cites·22 claims
- 1370US8513240B2Micronized tanaproget and compositions containing sameNAGI ARWINDER S·Filed 2010·Granted Aug 20, 2013·2 cites·16 claims
- 1459US8772271B2Micronized tanaproget, compositions, and methods of preparing the sameWYETH LLC·Filed 2013·Granted Jul 8, 2014·0 cites·38 claims
- 1558US2014328925A1Micronized tanaproget, compositions, and methods of preparing the sameWYETH LLC·Filed 2014·Application pending·0 cites
- 1657US2010062058A1Delayed Release Formulations for Oral Administration of a Polypeptide Therapeutic Agent and Methods of Using SameWYETH CORP·Filed 2009·Application pending·0 cites
- 1756US2008226714A1Sustained-release tablet formulations of piperazine-piperidine antagonists and agonists of the 5-ht1a receptor having enhanced intestinal dissolutionWYETH CORP·Filed 2008·Application pending·0 cites
- 1855US2014194398A1Tanaproget Compositions Containing Ethinyl EstradiolWYETH LLC·Filed 2014·Application pending·0 cites
- 1954US2008241234A1Pharmaceutical formulations of an anhydrate crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-olWYETH CORP·Filed 2007·Application pending·0 cites
- 2054US2008175901A1Pharmaceutical formulations of a crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-olWYETH CORP·Filed 2007·Application pending·0 cites
- 2154US2008175900A1Pharmaceutical formulations of an anhydrate crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-olWYETH CORP·Filed 2007·Application pending·0 cites
- 2254US2006280800A1Tanaproget compositions containing ethinyl estradiolWYETH CORP·Filed 2006·Application pending·0 cites
- 2354US2009239920A1Pharmaceutical formulations of an anhydrate crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-olWYETH CORP·Filed 2007·Application pending·0 cites
- 2452US8791109B2Compositions containing micronized tanaproget prepared by wet granulationWYETH LLC·Filed 2012·Granted Jul 29, 2014·0 cites·29 claims
- 2552US2006246128A1Micronized tanaproget and compositions containing sameWYETH CORP·Filed 2006·Application pending·0 cites
- 2652US2013337058A1Micronized Tanaproget and Compositions Containing SameWYETH LLC·Filed 2013·Application pending·0 cites
- 2751US2007207202A1Pharmaceutical formulations of a monohydrate crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-olWYETH CORP·Filed 2007·Application pending·0 cites
- 2851US2007208069A1Pharmaceutical formulations of an anhydrous crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-olWYETH CORP·Filed 2007·Application pending·0 cites
- 2949US8664208B2Tanaproget compositions containing ethinyl estradiolNAGI ARWINDER·Filed 2011·Granted Mar 4, 2014·0 cites·21 claims
- 3048US2007099931A1Pharmaceutical dosage forms and compositionsWYETH CORP·Filed 2006·Application pending·0 cites
- 3148US2004126358A1Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using sameFiled 2003·Application pending·0 cites
- 3243US2007003623A1Formulations of conjugated estrogens and bazedoxifeneWYETH CORP·Filed 2006·Application pending·0 cites
- 3341US2007208067A1Tablet Formulations and ProcessesWYETH CORP·Filed 2007·Application pending·0 cites
- 3440US2007207201A1Liquid and Semi-Solid Pharmaceutical Formulations and ProcessesWYETH CORP·Filed 2007·Application pending·0 cites
- 3533US2011165241A1Bazedoxifene formulations with antioxidantsWYETH LLC·Filed 2010·Application pending·0 cites
- 3633US2005215561A1Pharmaceutical dosage forms and compositionsGHOSH KRISHNENDU·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Arwinder Nagi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →